General Information of the Compound
Compound ID |
CP0013420
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
5-(3-Chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid
Show/Hide
|
||||||||||||||||||
Synonyms |
1009820-21-6
5-((3-Chlorophenyl)amino)benzo-[c][2,6]naphthyridine-8-carboxylic acid
5-((3-Chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid
5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid
5-[(3-Chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-Carboxylic Acid
5-[(3-chlorophenyl)amino]-Benzo[c]-2,6-naphthyridine-8-carboxylic acid
AK-82006
C19H12ClN3O2
C6RWP0N0L2
CHEMBL1230165
CX 4945
CX-4945
CX-4945 (Silmitasertib)
CX4945
Silmitasertib
UNII-C6RWP0N0L2
W-204393
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C19H12ClN3O2
|
||||||||||||||||||
Molecular Weight |
349.777
|
||||||||||||||||||
Canonical SMILES |
OC(=O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc21
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25)
Show/Hide
|
||||||||||||||||||
InChIKey |
MUOKSQABCJCOPU-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
1009820-21-6
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01210, Casein kinase II subunit alpha
Protein ID: PT01246, Casein kinase II subunit alpha'
Clinical Information about the Compound
Drug 1 ( CX-4945 )
Drug Name | CX-4945 | ||
---|---|---|---|
Company | Cylene Pharmaceuticals | ||
Indication | |||
Target(s) |